Breaking News Instant updates and real-time market news.

2020-11-29 17:57:11 LSPD Lightspeed $55.08 / +3.96 (+7.75%) 17:57 11/29/20 11/29 17:57 11/29/20 17:57	Lightspeed downgraded to Neutral from Buy at BTIG BTIG analyst Mark Palmer downgraded Lightspeed to Neutral from Buy after the company's share price exceeded his previous C$58 target. The analyst notes that shares have surged by 376% since he initiated coverage of the stock amidst the pandemic-driven March lows, including an increase of more than 68% during the past month versus a 7.0% increase in the S&P 500 during that span. Palmer remains constructive on Lightspeed's growth prospects as its cloud-based point-of-sale and payments offerings are rolled out to a $100B-plus restaurant and retail market. However, he believes a significant portion of that upside is already reflected in the stock's valuation.	30 Nov 11 Sep
LSPD Lightspeed $55.08 / +3.96 (+7.75%) 11/09/20 RBC Capital Lightspeed price target raised to $56 from $47 at RBC Capital 11/06/20 CIBC Lightspeed price target raised to C$67 from C$50 at CIBC 11/06/20 BMO Capital Lightspeed price target raised to C$62 from C$50 at BMO Capital 11/06/20 Scotiabank Lightspeed price target raised to C$56 from C$51 at Scotiabank

2020-11-29 17:57:11

LSPD

Lightspeed

$55.08 / +3.96 (+7.75%)

17:57

11/29/20

11/29

17:57

11/29/20

17:57

Lightspeed downgraded to Neutral from Buy at BTIG

BTIG analyst Mark Palmer downgraded Lightspeed to Neutral from Buy after the company's share price exceeded his previous C$58 target. The analyst notes that shares have surged by 376% since he initiated coverage of the stock amidst the pandemic-driven March lows, including an increase of more than 68% during the past month versus a 7.0% increase in the S&P 500 during that span. Palmer remains constructive on Lightspeed's growth prospects as its cloud-based point-of-sale and payments offerings are rolled out to a $100B-plus restaurant and retail market. However, he believes a significant portion of that upside is already reflected in the stock's valuation.

30
Nov

11
Sep

LSPD Lightspeed

$55.08 / +3.96 (+7.75%)

11/09/20 RBC Capital: Lightspeed price target raised to $56 from $47 at RBC Capital

11/06/20 CIBC: Lightspeed price target raised to C$67 from C$50 at CIBC

11/06/20 BMO Capital: Lightspeed price target raised to C$62 from C$50 at BMO Capital

11/06/20 Scotiabank: Lightspeed price target raised to C$56 from C$51 at Scotiabank

TODAY'S FREE FLY STORIES

Recommendations	Skyworks price target raised to $165 from $150 at Barclays » 06:51 01/26/21 01/26 06:51 01/26/21 06:51 SWKS Skyworks / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SWKS Skyworks / + 01/13/21 Skyworks announces milestone in SKY66318-21 power amplifier shipments 11/02/20 Skyworks up 1% to $144.00 after Q4 earnings beat SWKS Skyworks / + 01/25/21 Citi Skyworks price target raised to $164 from $137 at Citi 01/11/21 BofA Skyworks downgraded to Neutral from Buy at BofA 01/06/21 KeyBanc Skyworks price target raised to $180 from $170 at KeyBanc 12/14/20 Goldman Sachs Skyworks price target raised to $171 from $162 SWKS Skyworks / + 11/02/20 Skyworks sees Q1 EPS $2.06 at midpoint of revenue view, consensus $1.80 11/02/20 Skyworks reports Q4 EPS $1.85, consensus $1.52 11/02/20 Notable companies reporting after market close SWKS Skyworks / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/02/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 01/28/21 Skyworks - SWKS SWKS Skyworks / + 12/15/20 Early notable gainers among liquid option names on December 15th 12/04/20 Skyworks call volume above normal and directionally bullish 11/30/20 Skyworks call volume above normal and directionally bullish 11/25/20 Skyworks put volume heavy and directionally bearish
Recommendations	SiTime price target raised to $150 from $100 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 SITM SiTime / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SITM SiTime / + 12/15/20 SiTime announces 2B units of silicon MEMS timing solutions shipped 12/01/20 SiTime CFO sells 25K shares of common stock 09/18/20 SiTime CEO sells 30K shares of common stock 08/06/20 SiTime sees 'good chance' of additional revenue in Q3 from phone design win SITM SiTime / + 12/30/20 Roth Capital SiTime price target raised to $130 from $110 at Roth Capital 11/25/20 Lynx SiTime benefiting from October fire at AKM factory in Japan, says Lynx 11/05/20 Needham SiTime price target raised to $105 from $75 at Needham 10/15/20 Roth Capital SiTime price target raised to $110 from $80 at Roth Capital SITM SiTime / + 11/24/20 SiTime sees Q4 revenue up 10%-15% sequentially 11/04/20 SiTime reports Q3 EPS 23c, consensus 15c 08/31/20 SiTime raises Q3 revenue view from $28M-$29M to $31M-$32M, consensus $28.53M 08/05/20 SiTime reports Q2 EPS (14c), consensus (21c) 12 Jun SITM SiTime / + 08/31/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 02/03/21 SiTime - SITM
Recommendations	Silicon Labs price target raised to $150 from $135 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 SLAB Silicon Labs / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SLAB Silicon Labs / + 10/21/20 Silicon Labs and Teledyne e2v HiRel partner on high reliability isolation 09/29/20 Silicon Labs promotes Serena Townsend to vice president and Chief People Officer 09/21/20 Amazon Sidewalk working with Semtech, Silicon Labs and TI on new IoT chipsets 09/21/20 Silicon Labs, Amazon.com collaborate on Sidewalk SLAB Silicon Labs / + 01/25/21 Citi Silicon Labs price target raised to $165 from $121 at Citi 01/19/21 Fly Intel: Top five analyst initiations 01/19/21 Morgan Stanley Silicon Labs initiated with an Equal Weight at Morgan Stanley 12/30/20 Roth Capital Silicon Labs price target raised to $140 from $120 at Roth Capital SLAB Silicon Labs / + 10/28/20 Silicon Labs sees Q4 adjusted EPS 68c-78c, consensus 71c 10/28/20 Silicon Labs reports Q3 adjusted EPS 73c, consensus 73c 07/29/20 Silicon Labs sees Q3 adjusted EPS 67c-77c, consensus 64c 07/29/20 Silicon Labs reports Q2 adjusted EPS 74c, consensus 57c 02/03/21 Silicon Labs - SLAB
Recommendations	Qualcomm price target raised to $150 from $135 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 QCOM Qualcomm / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options QCOM Qualcomm / + 05:29 Today Veoneer, Qualcomm to collaborate on scalable ADAS/AD solutions 01/13/21 Qualcomm to acquire NUVIA for approximately $1.4B 01/13/21 Qualcomm to acquire NUVIA for approximately $1.4B 01/05/21 Qualcomm's Mollenkopf says 'right time' for Cristiano Amon to assume leadership QCOM Qualcomm / + 01/06/21 KeyBanc Skyworks price target raised to $180 from $170 at KeyBanc 01/06/21 KeyBanc Qualcomm price target raised to $180 from $175 at KeyBanc 01/05/21 Wells Fargo Wells Fargo sees 'seamless transition' for new Qualcomm CEO 01/05/21 Canaccord Qualcomm price target raised to $180 from $175 at Canaccord QCOM Qualcomm / + 11/04/20 Qualcomm sees Q1 adjusted EPS $1.95-$2.15, consensus $1.68 11/04/20 Qualcomm reports Q4 adjusted EPS $1.45, consensus $1.17 11/04/20 Notable companies reporting after market close 07/29/20 Qualcomm sees Q4 EPS $1.05-$1.25, consensus $1.10 QCOM Qualcomm / + 01/21/21 Qualcomm rolls out Snapdragon 870 series, DigiTimes reports 12/11/20 Apple begins work on own cellular modem, Bloomberg reports 12/09/20 Qualcomm to post 'strong' earnings, gross margins in 2021, DigiTimes reports 12/03/20 Samsung cuts foundry quotes for 5nm chip orders, DigiTimes reports QCOM Qualcomm / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 02/11/21 Technology & Internet Virtual Conference 02/03/21 Qualcomm - QCOM 03/10/21 Qualcomm Inc. QCOM Qualcomm / + 12/07/20 Qualcomm call buyer realizes 32% same-day gains 12/04/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Qualcomm call volume above normal and directionally bullish 11/11/20 Early notable gainers among liquid option names on November 11th
Recommendations	Qorvo price target raised to $185 from $160 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 QRVO Qorvo / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options QRVO Qorvo / + 01/11/21 Qorvo launches automotive eCall Switch 12/07/20 Poet Technologies appoints Glen Riley to board of directors 11/13/20 Zomedica expects to begin commercialization of TRUFORMA on March 30, 2021 11/05/20 Qorvo wins U.S. government project to create RF semiconductor packaging center QRVO Qorvo / + 01/25/21 Citi Qorvo price target raised to $188 from $144 at Citi 12/28/20 Mizuho Qorvo price target raised to $180 from $155 at Mizuho 12/22/20 Benchmark Qorvo price target raised to $185 from $155 at Benchmark 12/14/20 Goldman Sachs Qorvo price target raised to $190 from $180 at Goldman Sachs QRVO Qorvo / + 11/04/20 Qorvo sees Q4 non-GAAP EPS $2.65, consensus $1.90 11/04/20 Qorvo reports Q2 non-GAAP EPS $2.43, consensus $2.12 11/04/20 Notable companies reporting after market close 09/08/20 Qorvo raises Q2 EPS view to $2.14 from $1.90, consensus $1.91 QRVO Qorvo / + 09/08/20 Fly Intel: After-Hours Movers 07/30/20 Walmart, Target initiations among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 02/03/21 Qorvo - QRVO QRVO Qorvo / + 01/21/21 Unusually active option classes on open January 21st 12/15/20 Early notable gainers among liquid option names on December 15th 11/30/20 Early notable gainers among liquid option names on November 30th 11/11/20 Early notable gainers among liquid option names on November 11th

Earnings	Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) Consensus $8.99. Sees… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:49 Today Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Addex Therapeutics receives IND approval to start study in epilepsy JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:46 Today Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 03/01/21 41st Annual Healthcare Virtual Conference 08:30 Today Johnson & Johnson - JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Recommendations	NXP Semiconductors price target raised to $200 from $150 at Barclays » 06:50 01/26/21 01/26 06:50 01/26/21 06:50 NXPI NXP Semiconductors / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NXPI NXP Semiconductors / + 12/09/20 NXP Semiconductors' Owen sells over 7,000 common shares 12/02/20 NXP Semiconductors reports availability of 2nd genreation RF multichip modules 11/25/20 NXP Semiconductors CEO sells 10K shares of common stock 11/25/20 NXP Semiconductors chairman sells 12K shares of common stock NXPI NXP Semiconductors / + 01/15/21 Truist NXP Semiconductors price target raised to $209 from $165 at Truist 01/06/21 KeyBanc NXP Semiconductors price target raised to $195 from $190 at KeyBanc 12/28/20 Mizuho NXP Semiconductors price target raised to $173 from $155 at Mizuho 12/17/20 KeyBanc NXP Semiconductors price target raised to $190 from $160 at KeyBanc NXPI NXP Semiconductors / + 10/26/20 NXP Semiconductors reports Q3 EPS (8c) vs. 38c a year ago 10/26/20 NXP Semiconductors sees Q4 adjusted operating income $692M-$766M 10/26/20 NXP Semiconductors reports Q3 adj. operating income $586M vs. $687M a year ago 10/26/20 NXP Semiconductors sees Q4 revenue $2.38B-$2.53B, consensus $2.27B NXPI NXP Semiconductors / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 10/26/20 Fly Intel: After-Hours Movers 10/09/20 Fly Intel: Wall Street's top stories for Friday 02/02/21 NXP Semiconductors - NXPI NXPI NXP Semiconductors / + 10/01/20 NXP Semiconductors put volume heavy and directionally bearish 09/08/20 NXP Semiconductors put volume heavy and directionally bearish 09/04/20 NXP Semiconductors put volume heavy and directionally bearish 08/27/20 NXP Semiconductors call volume above normal and directionally bullish
Hot Stocks	Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 GMAB Genmab $42.68 / -0.41 (-0.95%) , JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) Genmab (GMAB) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GMAB JNJ GMAB Genmab $42.68 / -0.41 (-0.95%) 01/15/21 Genmab says Janssen granted FDA approval for Darzalez Faspro 01/13/21 Genmab achieves $40M milestone in AbbVie collaboration 01/04/21 Genmab announces initiation of innovaTV 301 trial 11/24/20 Genmab will not advance development of enapotamab vedotin after POC data JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Addex Therapeutics receives IND approval to start study in epilepsy 01/19/21 Royalty Pharma acquires royalty interest in Seltorexant from Minerva GMAB JNJ GMAB Genmab $42.68 / -0.41 (-0.95%) 01/25/21 DNB Markets Genmab downgraded to Sell from Hold at DNB Markets 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight on valuation at Morgan Stanley 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight from Overweight at Morgan Stanley 01/15/21 H.C. Wainwright Genmab price target raised to $49 from $44 at H.C. Wainwright JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 06:46 Today Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 03/01/21 41st Annual Healthcare Virtual Conference 08:30 Today Johnson & Johnson - JNJ JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Recommendations	Nvidia price target raised to $600 from $550 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 NVDA Nvidia / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NVDA Nvidia / + 01/17/21 Fly Intel: Top five weekend stock stories 01/10/21 Fly Intel: Top five weekend stock stories 01/10/21 Nio partners with Nvidia to develop new generation of automated driving EV 01/06/21 UK's CMA to investigate NVIDIA's takeover of Arm NVDA Nvidia / + 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/15/21 Truist Nvidia price target raised to $672 from $643 at Truist 01/15/21 Susquehanna Nvidia price target raised to $625 from $610 at Susquehanna 01/12/21 Wells Fargo Nvidia very-well positioned as gaming momentum continues, says Wells Fargo NVDA Nvidia / + 11/18/20 Nvidia sees Q4 revenue $4.8B +/- 2%, consensus $4.42B 11/18/20 Nvidia reports Q3 EPS $2.91, consensus $2.57 11/18/20 Notable companies reporting after market close 08/19/20 Nvidia sees Q3 revenue $4.4B, plus or minus 2%, consensus $3.97B NVDA Nvidia / + 01/16/21 Intel rebound will still take time, Barron's says 12/20/20 Chip makers under threat from big tech companies, WSJ reports 12/11/20 Samsung seeing yield issues for 8nm process, DigiTimes reports 12/08/20 Intel, Nvidia asked about tech sale to China used against Uighurs, Reuters says NVDA Nvidia / + 01/22/21 The Intersection: Crypto and Wall Street This Week 01/16/21 Charged: NIO unveils new sedan, Plug partners with Renault 01/15/21 The Intersection: Crypto and Wall Street This Week 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla NVDA Nvidia / + 01/11/21 Early notable gainers among liquid option names on January 11th 11/18/20 NVIDIA options imply 8.0% move in share price post-earnings 11/04/20 NVIDIA call buyer realizes 8% same-day gains 10/06/20 Early notable gainers among liquid option names on October 6th
Recommendations	Maxim Integrated price target raised to $95 from $74 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 MXIM Maxim Integrated / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MXIM Maxim Integrated / + 10/08/20 Analog Devices, Maxim Integrated shareholders approve merger 09/23/20 Maxim Integrated and Serial Microelectronics sign distribution agreement 07/28/20 Maxim Integrated says no dividend to be paid for next four quarters MXIM Maxim Integrated / + 01/25/21 Deutsche Bank Maxim Integrated price target raised to $101 from $95 at Deutsche Bank 12/17/20 Deutsche Bank Maxim Integrated price target raised to $95 from $90 at Deutsche Bank 11/25/20 Truist Analog Devices price target raised to $164 from $136 at Truist 08/20/20 RBC Capital Analog Devices price target raised to $135 from $130 at RBC Capital MXIM Maxim Integrated / + 10/27/20 Maxim Integrated reports Q1 EPS 72 ex-items, consensus 58c 10/27/20 Notable companies reporting after market close 07/28/20 Maxim Integrated reports Q4 adjusted EPS 58c, consensus 57c 07/28/20 Notable companies reporting after market close

Recommendations	Marvell price target raised to $60 from $50 at Barclays » 06:49 01/26/21 01/26 06:49 01/26/21 06:49 MRVL Marvell / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MRVL Marvell / + 12/23/20 Marvell VP Dean Jarnac sells $576K in company shares 12/15/20 Marvell says HSR waiting period in connection with Inphi acquisition has expired 12/03/20 Marvell CEO says Q3 revenue growth driven by networking business 12/03/20 Marvell sees Q4 adjusted gross margin approximately 64% MRVL Marvell / + 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/25/21 Citi Marvell price target raised to $64 from $50 at Citi 01/15/21 Susquehanna Marvell price target raised to $60 from $54 at Susquehanna 01/13/21 Piper Sandler Marvell price target raised to $60 from $50 at Piper Sandler MRVL Marvell / + 12/03/20 Marvell sees Q4 adjusted EPS 25c-33c, consensus 29c 12/03/20 Marvell reports Q3 adjusted EPS 25c, consensus 25c 10/29/20 Marvell sees Q3 revenue $750M +/- 2%, consensus $750.97M 08/27/20 Marvell sees Q3 adjusted EPS 22c-28c, consensus 25c MRVL Marvell / + 10/29/20 Marvell near deal to acquire Inphi for about $10B, WSJ reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says 08/13/20 Intel unveils transistor technology to boost chip performance, Reuters says MRVL Marvell / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Fly Insider:180 Degree Capital, AMC among week's notable insider trades 12/04/20 Fly Intel: Wall Street's top stories for Friday 12/04/20 Fly Intel: Wall Street's top stories at midday MRVL Marvell / + 12/21/20 Unusual call flow in option market yesterday 12/18/20 Call Seller in Marvell exits Dec trade for 97% loss 12/17/20 Marvell call volume above normal and directionally bullish 12/03/20 Marvell options imply 7.5% move in share price post-earnings
Recommendations	Lam Research price target raised to $600 from $405 at Barclays » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 LRCX Lam Research / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LRCX Lam Research / + 12/02/20 Lam Research VP Vahid Vahedi sells almost $1.3M in company shares 11/16/20 Lam Research CFO sells 8.2K shares of common stock 11/05/20 Lam Research announces $5B share repurchase authorization, quarterly dividend 08/27/20 Lam Research raises quarterly dividend 13% to $1.30 per share LRCX Lam Research / + 01/25/21 B. Riley Securities Lam Research price target raised to $650 from $600 at B. Riley Securities 01/25/21 Credit Suisse Lam Research price target raised to $650 from $450 at Credit Suisse 01/25/21 Deutsche Bank Lam Research price target raised to $575 from $500 at Deutsche Bank 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment LRCX Lam Research / + 10/21/20 Lam Research sees Q2 EPS $5.60, +/- 40c, consensus $5.16 10/21/20 Lam Research reports Q1 EPS $5.67, consensus $5.19 10/21/20 Notable companies reporting after market close 07/29/20 Lam Research sees Q3 EPS $5.15 +/- 40c, consensus $4.14 LRCX Lam Research / + 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports LRCX Lam Research / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 01/27/21 Lam Research - LRCX LRCX Lam Research / + 11/27/20 Early notable gainers among liquid option names on November 27th 10/06/20 Lam Research call volume above normal and directionally bullish 09/24/20 Early notable gainers among liquid option names on September 24th 09/02/20 Lam Research call volume above normal and directionally bullish
Recommendations	KLA Corp. price target raised to $300 from $220 at Barclays » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 KLAC KLA Corp. / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KLAC KLA Corp. / + 09/21/20 KLA Corp. appoints MaryBeth Wilkinson as EVP, chief legal officer 08/03/20 KLA Corp. raises annual dividend 15% to $3.60 per share KLAC KLA Corp. / + 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/25/21 Citi KLA Corp. price target raised to $360 from $236 at Citi 01/18/21 Goldman Sachs KLA Corp. price target raised to $308 from $271 at Goldman Sachs 01/08/21 Argus KLA Corp. price target raised to $300 from $235 at Argus KLAC KLA Corp. / + 10/28/20 KLA Corp. sees Q2 adjusted EPS $2.82-$3.46, consensus $2.80 10/28/20 KLA Corp. reports Q1 adjusted EPS $3.03, consensus $2.77 08/03/20 KLA Corp. sees Q1 adjusted EPS $2.42-$3.06, consensus $2.29 08/03/20 KLA Corp. reports Q4 adjusted EPS $2.73, consensus $2.41 KLAC KLA Corp. / + 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says KLAC KLA Corp. / + 08/03/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference 02/03/21 KLA Corp. - KLAC KLAC KLA Corp. / + 01/14/21 Early notable gainers among liquid option names on January 14th 12/24/20 Early notable gainers among liquid option names on December 24th
Recommendations	Broadcom price target raised to $500 from $450 at Barclays » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 AVGO Broadcom $465.17 / +0.57 (+0.12%) Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AVGO Broadcom $465.17 / +0.57 (+0.12%) 12/21/20 Broadcom CEO sells over 14,000 common shares 12/16/20 Synnex awarded commercial aggregator agreement with Broadcom 12/10/20 Broadcom CEO says 'we concluded the year with strong fourth quarter results' 12/10/20 Broadcom names Charlie Kawwas as COO, Kirsten Spears as CFO AVGO Broadcom $465.17 / +0.57 (+0.12%) 01/13/21 Piper Sandler AMD price target raised to $110 from $100 at Piper Sandler 01/11/21 JPMorgan Broadcom ASIC revenues recently passed $1B, says JPMorgan 01/07/21 Piper Sandler Piper boosts Broadcom target to $500, calls top large cap pick for 2021 12/30/20 Rosenblatt Activist a 'new stage in the Intel journey of decline,' says Rosenblatt AVGO Broadcom $465.17 / +0.57 (+0.12%) 12/10/20 Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B 12/10/20 Broadcom reports Q4 adjusted EPS $6.35, consensus $6.25 12/10/20 Notable companies reporting after market close 09/03/20 Broadcom sees Q4 revenue $6.4B, +/- $150M, consensus $6.18B AVGO Broadcom $465.17 / +0.57 (+0.12%) 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says AVGO Broadcom $465.17 / +0.57 (+0.12%) 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday AVGO Broadcom $465.17 / +0.57 (+0.12%) 11/03/20 Unusually active option classes on open November 3rd 09/04/20 Early notable gainers among liquid option names on September 4th 09/03/20 Broadcom options imply 7.0% move in share price post-earnings 08/31/20 Broadcom call volume above normal and directionally bullish
Recommendations	II-VI price target raised to $100 from $65 at Barclays » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 IIVI II-VI $91.44 / -2.54 (-2.70%) Barclays analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events IIVI II-VI $91.44 / -2.54 (-2.70%) 12/16/20 Coherent, II-VI enter supply agreement 12/16/20 II-VI, Coherent enter supply agreement for automotive laser welding solutions 10/05/20 II-VI appoints Sohail Khan to lead New Ventures & Wide-Bandgap Electronics Tech 09/04/20 FCC says U.S. rural telecom networks need $1.84B to remove Huawei, ZTE equipment IIVI II-VI $91.44 / -2.54 (-2.70%) 01/25/21 Citi Citi moves Marvell up to pick in semiconductor equipment 01/25/21 Citi II-VI price target raised to $110 from $65 at Citi 01/19/21 Needham II-VI price target raised to $98 from $71 at Needham 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 IIVI II-VI $91.44 / -2.54 (-2.70%) 11/05/20 II-VI sees Q2 non-GAAP EPS 86c-95c, consensus 63c 11/05/20 II-VI reports Q1 non-GAAP EPS 84c, consensus 55c 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 02 Jul IIVI II-VI $91.44 / -2.54 (-2.70%) 12/18/20 II-VI to enter supply chain for Apple's next-gen iPhones, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says 11/23/20 U.K. considers Huawei installation ban in 2021, Bloomberg says IIVI II-VI $91.44 / -2.54 (-2.70%) 11/05/20 Fly Intel: Pre-market Movers 03/15/21 33rd Annual Roth Virtual Conference

Hot Stocks	Merck: EC approves KEYTRUDA for treatment of MSI-H, dMMR colorectal cancer » 06:48 01/26/21 01/26 06:48 01/26/21 06:48 MRK Merck $81.15 / +0.19 (+0.23%) Merck announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK Merck $81.15 / +0.19 (+0.23%) 01/25/21 Merck ends work on COVID-19 vaccines, still working on therapeutic candidates 01/25/21 Merck discontinues development of COVID-19 vaccine candidates 01/20/21 Merck granted FDA approval of Verquvo for cardiosvacular risk reduction 01/19/21 Cocrystal Pharma completes research obligations under Merck agreement MRK Merck $81.15 / +0.19 (+0.23%) 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair 01/20/21 Citi Citi opens 'negative Catalyst Watch' on Bristol-Myers 01/06/21 Citi Citi opens 'positive catalyst watch' on Merck MRK Merck $81.15 / +0.19 (+0.23%) 10/27/20 Merck raises FY20 adjusted EPS view to $5.91-$6.01 from $5.63-$5.78 10/27/20 Merck reports Q3 adjusted EPS $1.74, consensus $1.43 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open MRK Merck $81.15 / +0.19 (+0.23%) 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports MRK Merck $81.15 / +0.19 (+0.23%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/25/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 02/04/21 Merck - MRK 02/09/21 Oncologic Drugs Advisory Committee Virtual Meeting 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 MRK Merck $81.15 / +0.19 (+0.23%) 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish 08/06/20 Unusually active option classes on open August 6th 08/05/20 Merck call volume above normal and directionally bullish
Recommendations	Applied Materials price target raised to $115 from $74 at Barclays » 06:47 01/26/21 01/26 06:47 01/26/21 06:47 AMAT Applied Materials / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AMAT Applied Materials / + 01/05/21 Applied Materials raises bid for Kokusai Electric to $3.5B 12/08/20 Applied Materials appoints Rani Borkar to its Board of Directors 10/22/20 Applied Materials, Besi enter agreement to develop chip integration technology 09/09/20 Applied Materials announces Growth Technical Advisory Board AMAT Applied Materials / + 06:44 Today DA Davidson Applied Materials upgraded to Buy from Neutral at DA Davidson 01/25/21 Citi Applied Materials price target raised to $130 from $80 at Citi 01/18/21 Goldman Sachs Applied Materials price target raised to $118 from $99 at Goldman Sachs 01/11/21 BofA BofA US 1 List changes AMAT Applied Materials / + 11/12/20 Applied Materials sees Q1 EPS $1.20-$1.32, consensus $1.11 11/12/20 Applied Materials reports Q4 adj. EPS $1.25, consensus $1.17 11/12/20 Notable companies reporting after market close 08/13/20 Applied Materials sees Q4 EPS $1.11-$1.23, consensus $1.02 AMAT Applied Materials / + 10/16/20 China's SAMR may wait until after U.S. election on approvals, Dealreporter says 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says AMAT Applied Materials / + 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/12/20 Fly Intel: After-Hours Movers 08/14/20 Fly Intel: Wall Street's top stories for Friday 08/14/20 Fly Intel: Wall Street's top stories at midday AMAT Applied Materials / + 01/14/21 Early notable gainers among liquid option names on January 14th 11/27/20 Early notable gainers among liquid option names on November 27th 11/13/20 Early notable gainers among liquid option names on November 13th 09/02/20 Applied Materials call volume above normal and directionally bullish
Recommendations	Analog Devices price target raised to $170 from $150 at Barclays » 06:47 01/26/21 01/26 06:47 01/26/21 06:47 ADI Analog Devices / + Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ADI Analog Devices / + 10/22/20 Analog Devices, NEC team to provide 5G O-RAN Massive MIMO radio for Rakuten Mobi 10/08/20 Analog Devices, Maxim Integrated shareholders approve merger 09/22/20 Analog Devices teams with Microsoft to mass produce 3D imaging products 09/08/20 Analog Devices CEO sells 27.5K shares of common stock ADI Analog Devices / + 01/14/21 RBC Capital Analog Devices price target raised to $174 from $150 at RBC Capital 01/06/21 KeyBanc Analog Devices price target raised to $175 from $160 at KeyBanc 12/17/20 Deutsche Bank Analog Devices price target raised to $150 from $142 at Deutsche Bank 12/16/20 Citi Citi sees 'substantial upside' to semi estimates after latest checks ADI Analog Devices / + 11/24/20 Analog Devices sees Q1 adj. EPS $1.30 +/- 10c, consensus $1.27 11/24/20 Analog Devices reports Q4 adj, EPS $1.44, consensus $1.32 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open ADI Analog Devices / + 08/22/20 'Underappreciated' Synaptics shares have more upside, Barron's says ADI Analog Devices / + 01/12/21 On, Lumentum seen among top semiconductors takeout candidates for 2021 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/24/20 Fly Intel: Pre-market Movers 02/17/21 Analog Devices - ADI 03/10/21 Analog Devices, Inc. ADI Analog Devices / + 10/20/20 Downside put Seller in Analog Devices 08/12/20 Analog Devices call volume above normal and directionally bullish 07/28/20 Analog Devices call volume above normal and directionally bullish
Initiation	Telefonica Brasil initiated with a Buy at UBS » 06:47 01/26/21 01/26 06:47 01/26/21 06:47 VIV Telefonica Brasil $8.39 / +0.205 (+2.50%) UBS initiated coverage of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research VIV Telefonica Brasil $8.39 / +0.205 (+2.50%) 10/15/20 Barclays Telefonica Brasil price target lowered to $9.50 from $10.50 at Barclays 05/04/20 Credit Suisse Telefonica Brasil upgraded to Outperform from Neutral at Credit Suisse 05/01/20 HSBC Telefonica Brasil upgraded to Buy from Hold at HSBC 04/22/20 JPMorgan Telefonica Brasil upgraded to Overweight from Neutral at JPMorgan
Recommendations	Allegro MicroSystems price target raised to $38 from $28 at Barclays » 06:46 01/26/21 01/26 06:46 01/26/21 06:46 ALGM Allegro MicroSystems $31.85 / -1.57 (-4.70%) Barclays analyst Blayne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events ALGM Allegro MicroSystems $31.85 / -1.57 (-4.70%) 12/28/20 Mizuho Allegro MicroSystems price target raised to $30 from $28 at Mizuho 11/23/20 Jefferies Allegro MicroSystems initiated with a Buy at Jefferies 11/23/20 Credit Suisse Allegro MicroSystems initiated with an Outperform at Credit Suisse 11/23/20 Mizuho Allegro MicroSystems initiated with a Buy at Mizuho ALGM Allegro MicroSystems $31.85 / -1.57 (-4.70%) 11/19/20 Allegro MicroSystems sees Q3 revenue $147M-$151M 11/19/20 Allegro MicroSystems reports Q2 EPS 96c vs. $1.16 last year 29 Oct ALGM Allegro MicroSystems $31.85 / -1.57 (-4.70%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut 02/02/21 Allegro MicroSystems - ALGM 03/04/21 Allegro MicroSystems

Earnings	Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 » 06:46 01/26/21 01/26 06:46 01/26/21 06:46 JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Addex Therapeutics receives IND approval to start study in epilepsy 01/19/21 Royalty Pharma acquires royalty interest in Seltorexant from Minerva JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/15/21 B. Riley Securities Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 12/29/20 Piper Sandler Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open 10/13/20 Johnson & Johnson sees 'robutst, double-digit sales growth' in 2021 10/13/20 Johnson & Johnson sees Q4 sales 'around' 2019 levels, consensus $21.52B JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/22/21 J&J director says company could boost vaccine availability by spring, CNBC says 01/13/21 Johnson & Johnson's one-dose COVID-19 vaccine appears 'promising,' CNBC says 01/13/21 J&J chief science officer sees possible vaccine approval by March, Reuters says 01/13/21 J&J sees U.S. decision on COVID-19 vaccine candidate by March, Bloomberg says JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/13/21 Fly Intel: Wall Street's top stories for Wednesday 12/29/20 Street Fight: Citi sees opportunity in Arcturus as COVID data prompts downgrades 03/01/21 41st Annual Healthcare Virtual Conference 08:30 Today Johnson & Johnson - JNJ JNJ Johnson & Johnson $165.91 / +2.23 (+1.36%) 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd 08/24/20 Unusually active option classes on open August 24th
Initiation	America Movil initiated with a Neutral at UBS » 06:45 01/26/21 01/26 06:45 01/26/21 06:45 AMX America Movil $14.44 / +0.165 (+1.16%) UBS initiated coverage of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AMX America Movil $14.44 / +0.165 (+1.16%) 09/15/20 New Street America Movil upgraded to Buy from Neutral at New Street 06/04/20 Itau BBA America Movil upgraded to Outperform from Market Perform at Itau BBA 04/30/20 Fly Intel: Top five analyst initiations 04/30/20 Barclays America Movil reinstated with an Overweight at Barclays
Downgrade	Flughafen Zuerich downgraded to Hold from Buy at Berenberg » 06:44 01/26/21 01/26 06:44 01/26/21 06:44 FLGZY Flughafen Zuerich $0.00 / + (+0.00%) Berenberg analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FLGZY Flughafen Zuerich $0.00 / + (+0.00%) 01/20/21 Barclays Flughafen Zuerich price target raised to CHF 166 from CHF 157 at Barclays 12/17/20 Morgan Stanley Flughafen Zuerich price target raised to CHF 169 from CHF 164 at Morgan Stanley 12/04/20 Deutsche Bank Flughafen Zuerich price target raised to CHF 182 from CHF 157 at Deutsche Bank 11/30/20 UBS Flughafen Zuerich downgraded to Neutral from Buy at UBS
Upgrade	Applied Materials upgraded to Buy from Neutral at DA Davidson » 06:44 01/26/21 01/26 06:44 01/26/21 06:44 AMAT Applied Materials $108.14 / +1.77 (+1.66%) DA Davidson analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AMAT Applied Materials $108.14 / +1.77 (+1.66%) 01/05/21 Applied Materials raises bid for Kokusai Electric to $3.5B 12/08/20 Applied Materials appoints Rani Borkar to its Board of Directors 10/22/20 Applied Materials, Besi enter agreement to develop chip integration technology 09/09/20 Applied Materials announces Growth Technical Advisory Board AMAT Applied Materials $108.14 / +1.77 (+1.66%) 01/25/21 Citi Applied Materials price target raised to $130 from $80 at Citi 01/18/21 Goldman Sachs Applied Materials price target raised to $118 from $99 at Goldman Sachs 01/11/21 BofA BofA US 1 List changes 01/07/21 Argus Applied Materials price target raised to $110 from $90 at Argus AMAT Applied Materials $108.14 / +1.77 (+1.66%) 11/12/20 Applied Materials sees Q1 EPS $1.20-$1.32, consensus $1.11 11/12/20 Applied Materials reports Q4 adj. EPS $1.25, consensus $1.17 11/12/20 Notable companies reporting after market close 08/13/20 Applied Materials sees Q4 EPS $1.11-$1.23, consensus $1.02 AMAT Applied Materials $108.14 / +1.77 (+1.66%) 10/16/20 China's SAMR may wait until after U.S. election on approvals, Dealreporter says 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports 09/03/20 China plans domestic semiconductor overhaul in Trump retaliation, Bloomberg says AMAT Applied Materials $108.14 / +1.77 (+1.66%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 11/12/20 Fly Intel: After-Hours Movers 08/14/20 Fly Intel: Wall Street's top stories for Friday 08/14/20 Fly Intel: Wall Street's top stories at midday AMAT Applied Materials $108.14 / +1.77 (+1.66%) 01/14/21 Early notable gainers among liquid option names on January 14th 11/27/20 Early notable gainers among liquid option names on November 27th 11/13/20 Early notable gainers among liquid option names on November 13th 09/02/20 Applied Materials call volume above normal and directionally bullish
Hot Stocks	Synovus reports Q4 net interest margin 3.12%, up 2 bps vs. Q3 06:44 01/26/21 01/26 06:44 01/26/21 06:44 SNV Synovus $36.66 / -0.63 (-1.69%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events SNV Synovus $36.66 / -0.63 (-1.69%) 06:42 Today Synovus says Kevin Blair will become CEO in April 11/22/20 Fly Intel: Top five weekend stock stories SNV Synovus $36.66 / -0.63 (-1.69%) 01/08/21 Piper Sandler Synovus price target raised to $40 from $37 at Piper Sandler 01/07/21 Jefferies Synovus upgraded to Buy with $40 price target at Jefferies 01/07/21 Jefferies Synovus upgraded to Buy from Hold at Jefferies 12/11/20 RBC Capital Synovus upgraded to Outperform on better credit and capital view at RBC Capital SNV Synovus $36.66 / -0.63 (-1.69%) 06:31 Today Synovus reports Q4 adjusted EPS $1.08, consensus 80c 10/20/20 Synovus reports Q3 adjusted EPS 89c, consensus 52c SNV Synovus $36.66 / -0.63 (-1.69%) 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 03/11/21 Virtual Atlanta and Texas Bank Summit 08:30 Today Synovus - SNV 02/09/21 Synovus

Events

Earnings calls, analyst events, roadshows and more

GE
Today at 08:00

General Electric - GE Conference Calls
BRO
Today at 08:00

Brown & Brown - BRO Conference Calls
ALV
Today at 08:00

Autoliv - ALV Conference Calls
XRX
Today at 08:00

Xerox - XRX Conference Calls
RYTM
Today at 08:00

Rhythm Pharmaceuticals - RYTM Conference Calls
LIQT
Today at 08:00

LiqTech International, Inc. Firm Sponsored Meetings

Virtual Meeting
VZ
Today at 08:30

Verizon - VZ Conference Calls
AUDC
Today at 08:30

AudioCodes - AUDC Conference Calls
JNJ
Today at 08:30

Johnson & Johnson - JNJ Conference Calls
PLUG
Today at 08:30

Plug Power - PLUG Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James $2.20 QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG $2.66 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares
Fri	No deals

View All Syndicate Announcements »

Lightspeed downgraded to Neutral from Buy at BTIG

TODAY'S FREE FLY STORIES

Get Full Fly Access